David A. Socks, Director at Phathom Pharmaceuticals, Inc. (PHAT), sold 106,344 shares at $48.32 ($5.1M) on 2021-03-10, disclosed to the SEC on 2021-03-12.
Open-market sale of $5.1M PHAT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.32 | 2,425 | $117K | 2.3% |
| 2 | $49.02 | 7,844 | $385K | 7.6% |
| 3 | $49.02 | 7,844 | $385K | 7.6% |
| 4 | $49.93 | 1,802 | $90K | 1.8% |
| 5 | $49.93 | 1,802 | $90K | 1.8% |
| 6 | $47.18 | 41,698 |
| $2.0M |
| 38.9% |
| 7 | $47.18 | 41,698 | $2.0M | 38.9% |
| 8 | $47.54 | 731 | $35K | 0.7% |
| 9 | $46.67 | 500 | $23K | 0.5% |
| Total | $47.57 avg | 106,344 | $5.1M | 100% |
| Filing → |
| PHAT | SELL | 2021-08-18 | $1.1M | — | Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |